SEQUENTIAL USE OF TARGET AGENTS AND THEIR COMBINATION IN THE TREATMENT FOR METASTATIC RENAL CELL CARCINOMA

SEQUENTIAL USE OF TARGET AGENTS AND THEIR COMBINATION IN THE TREATMENT FOR METASTATIC RENAL CELL CARCINOMA

Show other versions (1)

<span>The development of molecular biology led to the discovery of major pathogenetic pathways in the development of renal cell carcinoma (RCC), contributing to the designing of novel drugs to treat metastatic RCC, which belong to a group of target agents or tyrosine kinase inhibitors. Phases...

Full description

Bibliographic Details
Main Authors: B. Ya. Alekseyev, A. S. Kalpinsky
Format: Article
Language:Russian
Published: ABV-press 2014-08-01
Series:Onkourologiâ
Subjects:
metastatic renal cell carcinoma
target therapy
tyrosine kinase inhibitors
Online Access:http://oncourology.abvpress.ru/index.php/oncur/article/view/325

Internet

http://oncourology.abvpress.ru/index.php/oncur/article/view/325

Similar Items